Functional analysis of a novel cis-acting regulatory region within the human ankyrin gene (ANK-1) promoter

Molecular and Cellular Biology

Volumn 30, Issue 14, 2010, Pages 3493-3502

  Laflamme, Karina ^a   Owen, Ashley N ^a   Devlin, Emily E ^a   Yang, Mary Q ^a   Wong, Clara ^b   Steiner, Laurie A ^b   Garrett, Lisa J ^a   Elnitski, Laura ^a   Gallagher, Patrick G ^b   Bodine, David M ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN; CIS ACTING ELEMENT; DINUCLEOTIDE; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR IID;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ARTICLE; CELL FREE SYSTEM; CONSENSUS; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENE REGULATORY NETWORK; HEREDITARY SPHEROCYTOSIS; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENIC MOUSE; TRANSIENT TRANSFECTION;

5' UNTRANSLATED REGIONS; ANIMALS; ANKYRINS; BASE SEQUENCE; BINDING SITES; CELL-FREE SYSTEM; CONSENSUS SEQUENCE; DNA; DNA PRIMERS; GENE LIBRARY; HUMANS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; SEQUENCE HOMOLOGY, NUCLEIC ACID; TATA-BOX BINDING PROTEIN; TRANSCRIPTION FACTOR TFIID; TRANSCRIPTION, GENETIC;

MUS MUSCULUS;

EID: 77954373042     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00119-10     Document Type: Article

References (40)

1. An, X., and N. Mohandas. 2008. Disorders of red cell membrane. Br. J. Haematol. 141:367-375.
2. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
3. Antonarakis, S. E., S. H. Irkin, T. C. Cheng, A. F. Scott, J. P. Sexton, S. P. Trusko, S. Charache, and H. H. Kazazian, Jr. 1984. β-Thalassemia in American Blacks: novel mutations in the "TATA" box and an acceptor splice site. Proc. Natl. Acad. Sci. U. S. A. 81:1154-1158.
4. Antequera, F., and A. Bird. 1994. Predicting the total number of human genes. Nat. Genet. 8:114.
5. Blake, M. C., R. C. Jambou, A. G. Swick, J. W. Kahn, and J. C. Azizkhan. 1990. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol. Cell. Biol. 10:6632-6641.
6. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature 371:435-438. (Pubitemid 24302561)
7. Breathnach, R., and P. Chambon. 1981. Organization and expression of eucaryotic split genes coding for proteins. Annu. Rev. Biochem. 50:349-383.
8. Burke, T. W., and J. T. Kadonaga. 1997. The downstream core promoter element, DPE, is conserved from Drosophila to humans and is recognized by TAFII60 of Drosophila. Genes Dev. 11:3020-3031.
9. Carey, M., and S. T. Smale. 2000. Transcriptional regulation in eukaryotes: concepts, strategies, and techniques. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
10. Chalkley, G. E., and C. P. Verrijzer. 1999. DNA binding site selection by RNA polymerase II TAFs: a TAF(II)250-TAF(II)150 complex recognizes the initiator. EMBO J. 17:4835-4845.
11. De Gobbi, M., V. Viprakasit, J. R. Hughes, C. Fisher, V. J. Buckle, H. Ayyub, R. J. Gibbons, D. Vernimmen, Y. Yoshinaga, P. de Jong, J. F. Cheng, E. M. Rubin, W. G. Wood, D. Bowden, and D. R. Higgs. 2006. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 312:1215-1217.
12. Eber, S. W., J. M. Gonzalez, M. L. Lux, A. L. Scarpa, W. T. Tse, M. Dornwell, J. Herbers, W. Kugler, R. Ozcan, A. Pekrun, P. G. Gallagher, W. Schröter, B. G. Forget, and S. E. Lux. 1996. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat. Genet. 13:214-218.
13. Eber, S. W., A. Pekrun, A. Neufeldt, and W. Schröter. 1992. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann. Hematol. 64:88-92.
14. Edwards, J. B., J. Delort, and J. Mallet. 1991. Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5′ ends of mRNAs and for constructing cDNA libraries by in vitro amplification. Nucleic Acids Res. 19:5227-5232.
15. Epstein, D. J. 2009. cis-Regulatory mutations in human disease. Brief Funct. Genomic Proteomic 8:310-316.
16. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. U. S. A. 85:8998-9002.
17. Gallagher, P. G. 2005. Hematologically important mutations: ankyrin variants in hereditary spherocytosis. Blood Cells Mol. Dis. 35:345-347.
18. Gallagher, P. G., and B. G. Forget. 1998. Hematologically important mutations: spectrin and ankyrin variants in hereditary spherocytosis. Blood Cells Mol. Dis. 24:539-543.
19. Gallagher, P. G., and P. Jarlim. 2005. Red cell membrane disorders, p. 669-691. In R. Hoffman, E. J. Benz, Jr., S. Shattil, B. Furie, H. J. Cohen, L. E. Silberstein, and P. McGlave (ed.), Hematology: basic principles and practice, 4th ed. Elsevier, Inc., Philadelphia, PA.
20. Gallagher, P. G., D. G. Nilson, C. Wong, J. L. Weisbein, L. J. Garrett-Beal, S. W. Eber, and D. M. Bodine. 2005. A dinucleotide deletion in the ankyrin promoter alters gene expression, transcription initiation and TFIID complex formation in hereditary spherocytosis. Hum. Mol. Genet. 14:2501-2509.
21. Gallagher, P. G., M. Romana, W. T. Tse, S. E. Lux, and B. G. Forget. 2000. The human ankyrin-1 gene is selectively transcribed in erythroid cell lines despite the presence of a housekeeping-like promoter. Blood 96:1136-1143.
22. Gallagher, P. G., D. E. Sabatino, D. S. Basseres, D. M. Nilson, C. Wong, A. P. Cline, L. J. Garrett, and D. M. Bodine. 2001. Erythrocyte ankyrin promoter mutations associated with recessive hereditary spherocytosis cause significant abnormalities in ankyrin expression. J. Biol. Chem. 276:41683-41689.
23. Godal, H. C., and H. Heistø. 1981. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand. J. Hematol. 27:30-34.
24. Gross, P., and T. Oelgeschlager. 2006. Core promoter-selective RNA polymerase II transcription. Biochem. Soc. Symp. 73:225-236.
25. Kioussis, D., and R. Festenstein. 1997. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7:614-619.
26. Knüppel, R., P. Dietze, W. Lehnberg, K. Frech, and E. Wingender. 1994. TRANSFAC retrieval program: a network model database of eukaryotic transcription regulating sequences and proteins. J. Comput. Biol. 1:191-198.
27. Lagrange, T., A. N. Kapanidis, H. Tang, D. Reinberg, and R. H. Ebright. 1998. New core promoter element in RNA polymerase II-dependent transcription: sequence-specific DNA binding by transcription factor IIB. Genes Dev. 12:34-44. (Pubitemid 28083656)
28. Matys, V., E. Fricke, R. Geffers, E. Gössling, M. Haubrock, R. Hehl, K. Hornischer, D. Karas, A. E. Kel, et al. 2003. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 31:374-378.
29. Moi, P., V. Faà, M. G. Marini, I. Asunis, G. Ibba, A. Cao, and M. C. Rosatelli. 2004. A novel silent beta-thalassemia mutation in the distal CACCC box affects the binding and responsiveness to EKLF. Br. J. Haematol. 126:881-884.
30. Nagy, A., M. Gertsenstein, K. Vintersten, and R. Behringer (ed.). 2002. Manipulating the mouse embryo: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
31. Roeder, R. G. 1998. Role of general and gene-specific cofactors in the regulation of eukaryotic transcription. Cold Spring Harbor Symp. Quant. Biol. 63:201-218.
32. Sabatino, D. E., C. Wong, A. P. Cline, L. Pyle, L. J. Garrett, P. G. Gallagher, and D. M. Bodine. 2000. A minimal ankyrin promoter linked to a human gamma-globin gene demonstrates erythroid specific copy number dependent expression with minimal position or enhancer dependence in transgenic mice. J. Biol. Chem. 275:28549-28554.
33. Smale, S. T. 1994. Core promoter architecture for eukaryotic protein-coding sequences, p. 63-81. In R. C. Conaway and J. W. Conaway (ed.), Transcription: mechanisms and regulation. Raven Press, Inc., New York, NY.
34. Smale, S. T., and J. T. Kadonaga. 2003. The RNA polymerase II core promoter. Annu. Rev. Biochem. 72:449-479.
35. Smale, S. T., M. C. Schmidt, A. J. Berk, and D. Baltimore. 1990. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc. Natl. Acad. Sci. U. S. A. 87:4509-4513.
36. Steiner, L. A., Y. Maksimova, V. Schulz, C. Wong, D. Raha, M. C. Mahajan, S. M. Weissman, and P. G. Gallagher. 2009. Chromatin architecture and transcription factor binding regulate expression of erythrocyte membrane protein genes. Mol. Cell. Biol. 29:5399-5412.
37. Suzuki, Y., T. Tsunoda, J. Sese, H. Taira, J. Mizushima-Sugano, H. Hata, T. Ota, T. Isogai, T. Tanaka, Y. Nakamura, A. Suyama, Y. Sakaki, S. Morishita, K. Okubo, and S. Sugano. 2001. Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res. 11:677-684.
38. Suzuki, Y., R. Yamashita, K. Nakai, and S. Sugano. 2002. DBTSS: DataBase of human transcriptional start sites and full-length cDNAs. Nucleic Acids Res. 30:328-331. (Pubitemid 34679576)
39. Suzuki, Y., R. Yamashita, M. Shirota, Y. Sakakibara, J. Chiba, J. Mizushima-Sugano, K. Nakai, and S. Sugano. 2004. Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions. Genome Res. 14:1711-1718. (Pubitemid 39276428)
40. Thorpe, S. J., S. L. Thein, M. Sampietro, J. E. Craig, B. Mahon, and E. R. Huehns. 1994. Immunochemical estimation of haemoglobin types in red blood cells by FACS analysis. Br. J. Haematol. 87:125-132.